The FDA approves Lilly's once-weekly insulin efsitora for type 2 diabetes, raising Fc-fusion manufacturing, high-concentration pen, and capacity questions.
News|Articles|July 2, 2017
- Pharmaceutical Technology-07-02-2017
- Volume 41
- Issue 7
Dissolution Tester Eliminates Water Bath
A bathless dissolution tester from Distek operates without a water bath and associated maintenance.
The
eliminates the water bath and all associated maintenance while heater jackets raise media temperature from ambient to 37 °C in less than 15 minutes. Wireless in-shaft temperature sensors continuously monitor and display the in-vessel temperature for each vessel. The dissolution tester includes a touch screen, electronic tracking of serialized stirring elements, qualification status and due dates, and reporting and method storage capabilities.
Articles in this issue
about 9 years ago
Packaging Improves Medication Adherenceabout 9 years ago
The New World of Biopharmaceutical Manufacturingabout 9 years ago
Forty Years of Drug Product Manufacturing Advancesabout 9 years ago
Evolution of Dosage-Form Development and Manufacturing Strategiesabout 9 years ago
Advances in Analytical Testing Tools for the Bio/Pharma Industryabout 9 years ago
Ribbon Blenders for Specialty Applicationsabout 9 years ago
Coating Module Supports Easy Module Exchangeabout 9 years ago
Bioreactor Family Includes Single-Use Bagsabout 9 years ago
FDA Continues to Promote Quality Drug ProductionRelated to this article
Florin Muraru, Gourav Pandey, and Richard Jaenisch explain where human sign-off belongs as multi-agent AI and document-parsing models reach GxP.
In this episode of Ask the Expert, Siegfried Schmitt, PhD, vice president, Technical at Parexel, and Susan J. Schniepp, distinguished fellow at Nelson Labs, discuss how companies should approach post-approval changes to their CMC regulatory filings.
The EC has approved AstraZeneca's Trixeo Aerosphere as the first single-inhaler triple-combination therapy for asthma in the EU, based on phase e data showing improved lung function and fewer severe exacerbations in patients uncontrolled on standard ICS/LABA treatment.
In this episode of Pharma Fundamentals, Dr. Aleksandra Zuraw, senior veterinary pathologist at Charles River, provides an introduction to the use of digital pathology in drug development.
Swedish biotech companies have a broad and varied product pipeline that is attracting attention from venture capitalists and pharmaceutical companies.
The agency issued a direct final rule that supports the use of innovative testing methods to limit the use of animals and maintain existing safety standards.
Jaenisch, Muraru, and Pandey debate whether AI "slop" is infiltrating pharma SOPs and deviation reports and who should catch it first.
Trending on Pharmaceutical Technology
1
The FDA Finalizes Rule Recognizing Non-Animal Testing Methods, Building on Year-Long Reduction Push
2
EU Clears AstraZeneca's Trixeo for Asthma, Opening New Manufacturing Demand for Single-Inhaler Triple Therapy
3
Weekly Basal Insulin Efsitora: A New Biologics CMC Benchmark
4
Ask the Expert: Post-Approval Changes
5